These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35453295)

  • 1. The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma.
    Hirooka K; Kiuchi Y
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma and the ocular renin-angiotensin-aldosterone system: Update on molecular signalling and treatment perspectives.
    Buonfiglio F; Pfeiffer N; Gericke A
    Cell Signal; 2024 Oct; 122():111343. PubMed ID: 39127136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal ischemia-reperfusion leads to hypertension and changes in proximal tubule Na
    Lima NKS; Farias WRA; Cirilo MAS; Oliveira AG; Farias JS; Aires RS; Muzi-Filho H; Paixão ADO; Vieira LD
    Life Sci; 2021 Feb; 266():118879. PubMed ID: 33310030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
    Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
    Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
    Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma.
    Nitta E; Hirooka K; Tenkumo K; Fujita T; Nishiyama A; Nakamura T; Itano T; Shiraga F
    Cell Death Dis; 2013 Jul; 4(7):e711. PubMed ID: 23828574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II and aldosterone activate retinal microglia.
    Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
    Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone as a Possible Contributor to Eye Diseases.
    Higashide T; Hirooka K; Kometani M; Sugiyama K
    Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36461718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma.
    Jeon SJ; Hwang HB; Lee NY
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33256138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
    Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
    World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress.
    Manrique C; Lastra G; Habibi J; Wei Y; Morris EM; Stump CS; Sowers JR
    Methods Mol Med; 2007; 139():163-79. PubMed ID: 18287671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
    Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II and aldosterone in retinal vasculopathy and inflammation.
    Wilkinson-Berka JL; Suphapimol V; Jerome JR; Deliyanti D; Allingham MJ
    Exp Eye Res; 2019 Oct; 187():107766. PubMed ID: 31425690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Johnson M; Tilmon R; Rehmer N; Rehmer J; Wiedmeyer C; Ferrario CM; Sowers JR
    Am J Nephrol; 2009; 30(4):354-60. PubMed ID: 19609077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
    Wilkinson-Berka JL; Rana I; Armani R; Agrotis A
    Clin Sci (Lond); 2013 May; 124(10):597-615. PubMed ID: 23379642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma.
    Kimura A; Guo X; Noro T; Harada C; Tanaka K; Namekata K; Harada T
    Neurosci Lett; 2015 Feb; 588():108-13. PubMed ID: 25555796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma.
    Semba K; Namekata K; Guo X; Harada C; Harada T; Mitamura Y
    Cell Death Dis; 2014 Jul; 5(7):e1333. PubMed ID: 25032856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.